Percutaneous absorption and histopathology of a poloxamer-based formulation of capsaicin analog

International Journal of Pharmaceutics

Volumn 159, Issue 1, 1997, Pages 105-114

  Lee, Beom Jin ^a   Lee, Tae Sup ^a   Cha, Bong Jin ^b   Kim, Soon Hoe ^b   Kim, Won Bae ^b  

^a Kangwon National University   (South Korea)

^b Dong A Pharmaceutical Company   (South Korea)

Author keywords

Capsaicin analog; Histopathology; Penetration enhancers; Percutaneous absorption; Poloxamer based gels

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; ALCOHOL; CAPSAICIN DERIVATIVE; DRUG VEHICLE; MACROGOL 400; MYRISTIC ACID ISOPROPYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; POLOXAMER; PROPYLENE GLYCOL;

ADOLESCENT; ANIMAL TISSUE; ARTICLE; DRUG ABSORPTION; DRUG FORMULATION; DRUG PENETRATION; GEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; PH; PRIORITY JOURNAL; RAT; SKIN ABSORPTION; SPECIES DIFFERENCE; SYRIAN HAMSTER; TOPICAL DRUG ADMINISTRATION; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0031573919     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(97)00276-7     Document Type: Article

References (21)

1. Cooper E.R. Increased skin permeability for lipophilic molecules. J. Pharm. Sci. 73:1984;1153-1156.
2. Crimi N., Polosa R., Maccarrone C., Palermo B., Palermo F., Mistretta A. Effect of topical application with capsaicin on skin responses to bradykinin and histamine in man. Clin. Exp. Allergy. 22:1992;933-939.
3. Fang J.Y., Wu P.C., Huang Y.B., Tsai Y.H. In vivo percutaneous absorption of capsaicin, nonivamide and sodium nonivamide acetate from ointment bases: pharmacokinetic analysis in rabbits. Int. J. Pharm. 128:1996;169-177.
4. Fang J.Y., Wu P.C., Huang Y.B., Tsai Y.H. Percutaneous absorption of capsaicin, nonivamide and sodium nonivamide acetate from gel and ointment bases: in vitro formulation evaluations in pigs and in vivo bioengineering methods in humans. Int. J. Pharm. 130:1996;121-135.
5. Fang J.Y., Wu P.C., Huang Y.B., Tsai Y.H. In vivo percutaneous absorption of capsaicin, nonivamide and sodium nonivamide acetate from ointment bases: skin erythema test and non-invasive surface recovery technique in humans. Int. J. Pharm. 131:1996;143-151.
6. Gil H.J., Lee W.Y., Chi S.C. Skin permeation of Flurbiprofen through excised rat skin from poloxamer 407 gel. J. Korean Pharm. Sci. 24:1994;S27-32.
7. Hatanaka T., Katayama K., Koizumi T., Sgibayashi K., Morimoto Y. Time-dependent percutaneous absorption enhancing effect of ethanol. J. Control. Release. 33:1995;423-428.
8. Kawada T., Watanabe T., Katsura K., Takami H., Iwai K. Formation and metabolism of pungent principle of capsaicin fruits. Microdetermination of capsaicin by high-performance liquid chromatography with electrochemical detection. J. Chromatogr. 329:1985;99-105.
9. Kurihara-Bergstrom T., Knutson K., DeNoble L.J., Goates C.Y. Percutaneous absorption enhancement of an ionic molecule by ethanol-water system in human skin. Pharm. Res. 7:1990;762-766.
10. Lee B., Kim J.-H., Park N.-S., Kong J.-Y. KR-25018: A novel orally active analgesic with non-narcotic properties. Arch. Pharm. Res. 17:1994;304-308.
11. Miller S.C., Donovan M.D. Effect of poloxamer 407 gel on the miotic activity of pilocarpine nitrate in rabbits. Int. J. Pharm. 12:1982;147-152.
12. Miyazki S., Yokouchi C., Nakamura T., Hashiguchi N., How W., Takada M. Pluronic F-127 gels as a novel vehicle for rectal administration of indomethacin. Chem. Pharm. Bull. 34:1986;1801.
13. Ohara N., Takayama K., Nagai T. Influence of temperature on the percutaneous absorption for lipophilic and hydrophilic drugs across the rat skin pretreated with oleic acid. Int. J. Pharm. 123:1995;281-284.
14. Park Y.-H., You E.-S., Kim W.-B., Lee S.-S. DA-5018, a novel vanilloid type analgesic. Arch. Pharmacal Res. 20(1):1997;93-95.
15. Saettone M.F., Giannaccini B., Delmonte G., Campigli V., Tota G., Marca F.L. Solubilization of tropicamide by poloxamers: physicochemical data and activity data in rabbits and humans. Int. J. Pharm. 43:1988;67-76.
16. Shim H.-J., Lee J.-J., Lee S.-D., Kim W.-B., Yang J., Kim S.-H., Lee M.G. Stability, blood partitioning and protein binding of DA-5018, a new nonnarcotic analgesic. Res. Commun. Mol. Pathol. Pharmacol. 91(1):1996;97-108.
17. Tominak R.L., Spyker D.A. Capsaicin and capsicum - a review: case report of the use of hot peppers in child abuse. Clin. Toxicol. 27:1987;591-601.
18. Touitou E., Fabin B. Altered skin permeation of a highly lipophilic molecule: tetrahydrocannabinol. Int. J. Pharm. 43:1988;17-22.
19. Tsai Y.H., Huang Y.B., Fang J.Y., Wu P.C. Percutaneous absorption of capsaicin and its derivatives. Drug Dev. Ind. Pharm. 20(4):1994;719-730.
20. Wade, A., Weller, P.J., 1994. Handbook of Pharmaceutical Excipients, 2nd ed. Pharmaceutical Press, London.
21. Wester, R.C., Maibach, H.I., 1993. Animal models for percutaneous absorption. In: Shah, V.P., Maibach, H.I. (Eds.), Topical Drug Bioavailability, Bioequivalence and Penetration. Plenum, New York, pp. 333-349.